A Phase 1 Two-way Cross-over Study of the Pharmacokinetics and Pharmacodynamics of Crystalline PX-866 Tablets and Amorphous PX-866 Capsules Administered in the Fasting State, and of Crystalline PX-866 Tablets Administered Fed and Fasting, in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Sonolisib (Primary)
- Indications Cancer
- Focus Pharmacokinetics
- 15 Mar 2012 Actual patient number 39 added as reported by ClinicalTrials.gov.
- 15 Mar 2012 Actual end date Jan 2012 added as reported by ClinicalTrials.gov.
- 15 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.